Oxford Cannabinoid Technologies Holdings Plc
LSE: OCTP.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Clarissa Ann Sowemimo-Coker
- Employees
- 7
- Headquarters
- London, United Kingdom
- IPO year
- 2021
- Market cap
- £1.3M
- Website
- https://www.oxcantech.com
Loading OCTP…
Loading profile data…Frequently asked questions about OCTP
What does Oxford Cannabinoid Technologies Holdings Plc (OCTP.L) do?
Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate is OCT461201, a selective CB2 receptor agonist in solid oral dosage form that is in pre-clinical development for use in the treatment of IBS-assoc...
Where does OCTP.L trade?
Oxford Cannabinoid Technologies Holdings Plc (OCTP.L) trades on the London Stock Exchange.
What sector is OCTP.L in?
Oxford Cannabinoid Technologies Holdings Plc (OCTP.L) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Oxford Cannabinoid Technologies Holdings Plc?
Clarissa Ann Sowemimo-Coker is the chief executive officer of Oxford Cannabinoid Technologies Holdings Plc (OCTP.L).
Where is Oxford Cannabinoid Technologies Holdings Plc headquartered?
Oxford Cannabinoid Technologies Holdings Plc is headquartered in United Kingdom.
Does OCTP.L pay a dividend?
Oxford Cannabinoid Technologies Holdings Plc (OCTP.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OCTP.L go public?
Oxford Cannabinoid Technologies Holdings Plc (OCTP.L) completed its initial public offering in 2021.